Question 1

What is the catalog number for Compound NP-022927?

Accepted Answer

The catalog number for Compound NP-022927 is T128509.

Question 2

Is Compound NP-022927 in stock?

Accepted Answer

Compound NP-022927 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 3

Who manufactures Compound NP-022927?

Accepted Answer

Compound NP-022927 is manufactured by Molfinity.

Question 4

What is the estimated delivery time for Compound NP-022927?

Accepted Answer

Estimated delivery time for Compound NP-022927 is approximately 10 business day(s), depending on your location.

Question 5

What is the immunogen used to generate this antibody?

Accepted Answer

Immunogen or antigen details used to raise this antibody are listed on the product datasheet under immunogen information.

Question 6

What is the recommended positive control for this assay?

Accepted Answer

A recommended positive control, where one is specified by the manufacturer, is listed on the datasheet or in the assay protocol.

Question 7

How should this product be stored?

Accepted Answer

Storage conditions depend on the specific reagent and are listed on the product datasheet, with most antibodies and proteins requiring -20°C unless stated otherwise. It is your responsibility to store the product correctly immediately upon receipt; damage from improper storage after delivery is not eligible for replacement.

Compound NP-022927

Product Specifications

Available Sizes

Frequently Asked Questions

Explore Other Products

CD4 Recombinant Rabbit mAb, BF405 conjugated

hsa-miR-1273 Primers

Hoxd9, ID (Hoxd9, Hox-4.4, Hoxd-9, Homeobox protein Hox-D9, Homeobox protein Hox-4.4, Homeobox protein Hox-5.2) (MaxLight 650) discontinued

RPS20P25 3'UTR Luciferase Stable Cell Line

Rabbit anti-human StAR-related lipid transfer (START) domain containing 8 polyclonal Antibody

Rabbit anti-human StAR-related lipid transfer (START) domain containing 8 polyclonal Antibody